They will burn half the cash and the rest will be paid out in ridiculous salaries and bonuses.
For those of a charting orientation, the stock is already in overbought territory / but the muppets and naive will probably chase it a bit more before the execs start selling into the strength.
And I’d check your numbers, as I’d be surprised if half the valuation is cash - but just because it is, does not imply that the IP is of equivalent value - because until it passes Phase III clinical trials AND is approved by FDA, it’s basically not worth a razoo!
DDD
BNO Price at posting:
4.3¢ Sentiment: Sell Disclosure: Not Held